<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1437">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05142449</url>
  </required_header>
  <id_info>
    <org_study_id>AMOXI</org_study_id>
    <nct_id>NCT05142449</nct_id>
  </id_info>
  <brief_title>Effect of Systemic Antibiotic Therapy on Postoperative Complications in Patients Undergoing Wisdom Teeth Removal Surgery.</brief_title>
  <official_title>Effect of Systemic Antibiotic Therapy on Postoperative Complications in Patients Undergoing Wisdom Teeth Removal Surgery. A Double-blind, Randomised, Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      59 medically healthy patients, who are scheduled for third molar extraction surgery and give&#xD;
      informed consent for the trial, are operated using a split-mouth technique.&#xD;
&#xD;
      One group of patients will be assigned to the test group (Amoxilan) for the first surgery and&#xD;
      to the control group (placebo) for the second surgery, and vice versa, according to&#xD;
      randomisation.&#xD;
&#xD;
      Patients receive 8 capsules Amoxilan or placebo (according to randomisation) perioperatively,&#xD;
      and 6 capsules Amoxilan/placebo per day for 3 days postoperativeley.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 25, 2019</start_date>
  <completion_date type="Anticipated">March 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mouth opening restrictions: Change of interincisal distance</measure>
    <time_frame>preoperatively as well as on the 1st and 7th postoperative day</time_frame>
    <description>Interincisal distance, with maximum mouth opening, is measured with a ruler.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of swelling</measure>
    <time_frame>preoperatively as well as on the 1st and 7th postoperative day</time_frame>
    <description>Swelling in the cheek area will be determined using a tape measure and 3D photographs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Visual Analogue Scale (VAS): Bleeding</measure>
    <time_frame>day of surgery, and on day 1, 2, 3, 4, 5, 6, 7 after surgery</time_frame>
    <description>Patients indicate bleeding symptoms on a VAS scale, ranging from 0-10, whereas higher values indicate a worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Visual Analogue Scale (VAS): Swelling</measure>
    <time_frame>day of surgery, and on day 1, 2, 3, 4, 5, 6, 7 after surgery</time_frame>
    <description>Patients indicate swelling on a VAS scale, ranging from 0-10, whereas higher values indicate a worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Visual Analogue Scale (VAS): Pain</measure>
    <time_frame>day of surgery, and on day 1, 2, 3, 4, 5, 6, 7 after surgery</time_frame>
    <description>Patients indicate pain on a VAS scale, ranging from 0-10, whereas higher values indicate a worse outcome</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">59</enrollment>
  <condition>Third Molar Extraction Surgery</condition>
  <arm_group>
    <arm_group_label>Amoxilan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive 8 capsules Amoxilan perioperatively and for the next 3 days 6 capsules per day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients receive 8 capsules Placebo perioperatively and for the next 3 days 6 capsules per day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amoxilan</intervention_name>
    <description>Patients receive 8 capsules Amoxilan perioperatively and for the next 3 days 6 capsules per day</description>
    <arm_group_label>Amoxilan</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Patients receive 8 capsules placebo perioperatively and for the next 3 days 6 capsules per day</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Symptom-free, bilaterally located third molars&#xD;
&#xD;
          -  Medically healthy patient ≥ 16 years&#xD;
&#xD;
          -  No allergies/intolerances against the investigational product/placebo&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  General contraindications to wisdom tooth extraction surgery&#xD;
&#xD;
          -  (Former) heavy smoking&#xD;
&#xD;
          -  Use of antibiotics within the last three months or patients requiring antibiotic&#xD;
             treatment prior to surgery&#xD;
&#xD;
          -  (Planned) Pregnancy/lactating&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael Payer, Prof. Dr.</last_name>
    <phone>0043 316 385 80659</phone>
    <email>mi.payer@medunigraz.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medizinische Universität Graz, Klin. Abteilung für Orale Chirurgie und Kieferorthopädie</name>
      <address>
        <city>Graz</city>
        <zip>8010</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Payer, Prof. Dr.</last_name>
      <email>mi.payer@medunigraz.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 24, 2021</study_first_submitted>
  <study_first_submitted_qc>November 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2021</study_first_posted>
  <last_update_submitted>November 24, 2021</last_update_submitted>
  <last_update_submitted_qc>November 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

